Cough, Cold and Allergy (Hay Fever) Remedies in Brazil

Date: September 23, 2016
Pages: 32
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CDC82D1DC2EEN
Leaflet:

Download PDF Leaflet

In 2016, cough, cold and allergy (hay fever) remedies accounted for 35% of overall value sales of OTC products in Brazil and remained the second largest category overall within consumer health. During the same year, the category posted current value growth of 8% to reach sales of B$5.9 billion, a performance which was slower than the current value CAGR of 10% recorded over the review period. This slowdown can be mainly attributed to strong fall in general consumption which has resulted from the...

Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antihistamines/Allergy Remedies (Systemic), Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Medicated Confectionery, Paediatric Cough, Cold and Allergy Remedies, Pharyngeal Preparations.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Cough, Cold and Allergy (Hay Fever) Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Trends
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016
  Table 3 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  Table 4 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016
  Table 5 Sales of Decongestants by Category: Value 2011-2016
  Table 6 Sales of Decongestants by Category: % Value Growth 2011-2016
  Table 7 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2012-2016
  Table 8 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2016
  Table 9 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
  Table 10 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 1 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Competitive Positioning
  Summary 2 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2016
Ems SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 3 EMS SA: Key Facts
Competitive Positioning
  Summary 4 EMS SA: Competitive Position 2016
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 5 Hypermarcas SA: Key Facts
  Summary 6 Hypermarcas SA: Operational Indicators
Competitive Positioning
  Summary 7 Hypermarcas SA: Competitive Position 2016
Sanofi-aventis Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
  Summary 8 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Competitive Positioning
  Summary 9 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2016
Executive Summary
Economic Slowdown Persists, Affecting Non-priority Categories More Intensely
Increasing Acceptance of Self-medication/self-care Due To Broadened Accessibility
Aggressive Pricing of Private Label Products Threatens the Competitiveness of Manufacturers
Sports Nutrition Manufacturers Expand Their Portfolios and Invest in Segmentation
Consumer Health Is Expected To Grow at A Slower Pace Over the Forecast Period
Key Trends and Developments
OTC Performs Relative Well During the Economic Slowdown As Growth Rates Slow
Health and Wellness Trend Dips As Prioritisation of Spending Negative Influences Sales of Vitamins and Dietary Supplements
Affordability Gains More Importance in the Strategies of Manufacturers
Market Indicators
  Table 11 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
  Table 12 Life Expectancy at Birth 2011-2016
Market Data
  Table 13 Sales of Consumer Health by Category: Value 2011-2016
  Table 14 Sales of Consumer Health by Category: % Value Growth 2011-2016
  Table 15 NBO Company Shares of Consumer Health: % Value 2012-2016
  Table 16 LBN Brand Shares of Consumer Health: % Value 2013-2016
  Table 17 Distribution of Consumer Health by Format: % Value 2011-2016
  Table 18 Distribution of Consumer Health by Format and Category: % Value 2016
  Table 19 Forecast Sales of Consumer Health by Category: Value 2016-2021
  Table 20 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
  Summary 10 Research Sources












Skip to top


Ask Your Question

Cough, Cold and Allergy (Hay Fever) Remedies in Brazil
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: